Content by Adrian Hernandez, C. Michael White
The FDA’s Weak Drug Manufacturing Oversight Is a Potentially Deadly ProblemCurrent manufacturing oversight in the United States and overseas is hampered by staff shortages and limited funding
Wed, 08/04/2021 - 12:01
T he U.S. Food and Drug Administration (FDA) regularly inspects manufacturing facilities to ensure that drugs meet rigorous quality standards. These standards are vital to protect patients from drugs that are incorrectly dosed, contaminated, or…